This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Devrim, E. Articles by Durak, I. Search for Related Content PubMed PubMed Citation Articles by Devrim, E. Articles by Tarhan, I. Articles by Ergüder, I. B. Articles by Durak, I. Social Bookmarking                         What's this?

Oxidant/Antioxidant Status of Placenta, Blood, and Cord Blood Samples From Pregnant Women Supplemented With Iron

rfan Tarhan, MD

mge B. Ergüder, MD

Ankara University School of Medicine, Department of Biochemistry, Ankara, Turkey; Zekai Tahir Burak Woman Health Teaching and Research Hospital, obstetrics and Gynecology Clinics, Ankara, Turkey

lker Durak, PhD

Ankara University School of Medicine, Department of Biochemistry, Ankara, Turkey; Zekai Tahir Burak Woman Health Teaching and Research Hospital, obstetrics and Gynecology Clinics, Ankara, Turkey; Ankara Üniversitesi Tip Fakültesi, Biyokimya Anabilim Dali, Dekanlik Binasi, Sihhiye 06100, Ankara, Turkey ilker_durak{at}yahoo.com

Objective: In this study, it was aimed to investigate oxidant/antioxidant status in placenta and in blood and cord blood samples from pregnant women supplemented with iron during pregnancy.

Methods: For this purpose, 27 pregnant women at admission for delivery participated in the study. Fifteen of them did not take iron tablets and the others took oral iron supplements during pregnancy. Following delivery, part of the placenta and blood and cord blood samples were taken from the mothers. In these samples, oxidant parameters (malondialdehyde [MDA] levels and xanthine oxidase [XO] activities) and antioxidant parameters (antioxidant potential [AOP] values, superoxide dismutase [SOD], catalase [CAT] and glutathione peroxidase [GSH-Px] activities) were studied.

Results: It was found that MDA level and SOD activities increased significantly in the placentas from the iron-supplemented group as compared with those from the control group. We also obsewrved that activities of SOD and XO enzymes in maternal erythrocytes, XO in cord blood erythrocytes and GSH-Px activities in cord blood plasma decreased significantly. However, activities of CAT and GSH-Px enzymes in cord blood erythrocytes and MDA levels in maternal plasma increased in the iron-supplemented group as compared with those from the control group.

Conclusion: Increased MDA levels in the maternal plasma and the placenta in the iron-supplemented group suggests that iron supplementation may contribute to increased oxidative stress in women taking iron supplements during pregnancy.

Key Words: Pregnancy • iron supplementation • oxidant/antioxidant status

Journal of the Society for Gynecologic Investigation, Vol. 13, No. 7, 502-505 (2006)
DOI: 10.1016/j.jsgi.2006.07.004


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?